Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
Overexpression of CD3 eta during thymic development does not alter the negative selection process. [electronic resource] by
- Hussey, R E
- Clayton, L K
- Diener, A
- McConkey, D J
- Howard, F D
- Rodewald, H R
- D'Adamio, L
- Dallenbach, F
- Stein, H
- Schmidt, E V
Producer: 19930315
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 150
Availability: No items available.
|
|
88.
|
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. [electronic resource] by
- Inoue, K
- Slaton, J W
- Perrotte, P
- Davis, D W
- Bruns, C J
- Hicklin, D J
- McConkey, D J
- Sweeney, P
- Radinsky, R
- Dinney, C P
Producer: 20010419
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
89.
|
Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis. [electronic resource] by
- Xie, K
- Huang, S
- Wang, Y
- Beltran, P J
- Juang, S H
- Dong, Z
- Reed, J C
- McDonnell, T J
- McConkey, D J
- Fidler, I J
Producer: 19970102
In:
Cancer immunology, immunotherapy : CII vol. 43
Availability: No items available.
|
|
90.
|
|
|
91.
|
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. [electronic resource] by
- Bruns, C J
- Harbison, M T
- Davis, D W
- Portera, C A
- Tsan, R
- McConkey, D J
- Evans, D B
- Abbruzzese, J L
- Hicklin, D J
- Radinsky, R
Producer: 20000829
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
92.
|
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. [electronic resource] by
- Bouvet, M
- Bold, R J
- Lee, J
- Evans, D B
- Abbruzzese, J L
- Chiao, P J
- McConkey, D J
- Chandra, J
- Chada, S
- Fang, B
- Roth, J A
Producer: 19990308
In:
Annals of surgical oncology vol. 5
Availability: No items available.
|
|
93.
|
Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. [electronic resource] by
- Marin, M C
- Fernandez, A
- Bick, R J
- Brisbay, S
- Buja, L M
- Snuggs, M
- McConkey, D J
- von Eschenbach, A C
- Keating, M J
- McDonnell, T J
Producer: 19960722
In:
Oncogene vol. 12
Availability: No items available.
|
|
94.
|
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. [electronic resource] by
- Slaton, J W
- Karashima, T
- Perrotte, P
- Inoue, K
- Kim, S J
- Izawa, J
- Kedar, D
- McConkey, D J
- Millikan, R
- Sweeney, P
- Yoshikawa, C
- Shuin, T
- Dinney, C P
Producer: 20011004
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7
Availability: No items available.
|
|
95.
|
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. [electronic resource] by
- Shaheen, R M
- Tseng, W W
- Davis, D W
- Liu, W
- Reinmuth, N
- Vellagas, R
- Wieczorek, A A
- Ogura, Y
- McConkey, D J
- Drazan, K E
- Bucana, C D
- McMahon, G
- Ellis, L M
Producer: 20010329
In:
Cancer research vol. 61
Availability: No items available.
|
|
96.
|
Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. [electronic resource] by
- Bold, R J
- Hess, K R
- Pearson, A S
- Grau, A M
- Sinicrope, F A
- Jennings, M
- McConkey, D J
- Bucana, C D
- Cleary, K R
- Hallin, P A
- Chiao, P J
- Abbruzzese, J L
- Evans, D B
Producer: 20000510
In:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract vol. 3
Availability: No items available.
|
|
97.
|
Phase II trial of imatinib mesylate in patients with metastatic melanoma. [electronic resource] by
- Kim, K B
- Eton, O
- Davis, D W
- Frazier, M L
- McConkey, D J
- Diwan, A H
- Papadopoulos, N E
- Bedikian, A Y
- Camacho, L H
- Ross, M I
- Cormier, J N
- Gershenwald, J E
- Lee, J E
- Mansfield, P F
- Billings, L A
- Ng, C S
- Charnsangavej, C
- Bar-Eli, M
- Johnson, M M
- Murgo, A J
- Prieto, V G
Producer: 20080917
In:
British journal of cancer vol. 99
Availability: No items available.
|
|
98.
|
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. [electronic resource] by
- Potts, B C
- Albitar, M X
- Anderson, K C
- Baritaki, S
- Berkers, C
- Bonavida, B
- Chandra, J
- Chauhan, D
- Cusack, J C
- Fenical, W
- Ghobrial, I M
- Groll, M
- Jensen, P R
- Lam, K S
- Lloyd, G K
- McBride, W
- McConkey, D J
- Miller, C P
- Neuteboom, S T C
- Oki, Y
- Ovaa, H
- Pajonk, F
- Richardson, P G
- Roccaro, A M
- Sloss, C M
- Spear, M A
- Valashi, E
- Younes, A
- Palladino, M A
Producer: 20110707
In:
Current cancer drug targets vol. 11
Availability: No items available.
|